多聚体

duō jù tǐ
  • polymer;multimer
多聚体多聚体
  1. 新型小分子抗体scFv多聚体与肿瘤靶向因此研发一种高效靶向性基因导入系统成为当务之急。

    New Type Recombinant Antibody Fragment scFv Multimer and Cancer Targeting So , It is very urgent for developing an cancer targeting gene transfer system .

  2. 牛精浆蛋白BSP所具有的Ⅱ型结构特点,形成多聚体结构,可与精子表面的磷脂结合,促进肝素和HDL诱发的牛附睾精子获能。

    The type ⅱ - modules of BSP proteins forms a multimer structure which can bind to the phospholipids on sperm surface and promote sperm capacitation induced by heparin and HDL in bovine epididymis .

  3. 血红蛋白也能交联到水溶性多聚体上,形成所谓的共轭血红蛋白

    Hemoglobin can also be cross-linked to solublepolymers to form so-called conjugated hemoglobin .

  4. HPLC法检人血白蛋白中多聚体含量

    HPLC Determination of Polymer in Human Serum Albumin

  5. coli中降解,并在一定条件下形成多聚体。

    Coli is easy to degrade and form aggregates in certain conditions .

  6. 对p(3HB-co-3HH)/PU这种全新的共聚多聚体支架材料的生物相容性进行评估;

    Evaluates the biocompatibility of p ( 3HB-co-3HH ) / PU , a new copolymer scaffold .

  7. 对生物可吸收材料p(3HB-co-3HH)/PU共聚多聚体的生物相容性进行评估。

    Objective To evaluate the biocompatibility of p ( 3HB-co-3HH ) / PU-A new biodegradable co-polymer scaffold .

  8. 本研究使用了光镊微吸管系统对VWF多聚体的拉伸进行了研究。

    In this study , we stretched plasma-derived VWF multimers by optical tweezers and micropipette .

  9. 采用热稳定性试验,以HPLC法测得的人血白蛋白多聚体含量为考察指标,确定人血白蛋白的贮存有效期。

    Throuth the heat stability test , the valid period of human albumin was calculated by determinating the containing of polymers & aggreates with a HPLC method .

  10. 总离子色谱质谱图(TIC)表明:多聚体RD中二聚体含量最高,热稳定性最好。

    It is found from TIC of GC-EIMS that the amount of dipolymer in RD is the largest with best thermal stability .

  11. 同时,VWF与血小板的粘附活性直接与其多聚体的分子量大小成正相关。

    The adhesive activity of VWF is positively correlated with the size of the multimers in plasma .

  12. 化学法主要采用脂类、肽类、多聚体等化学物质,此类物质带有正电荷,通过电荷偶联作用可将携带负电荷的DNA导入细胞。

    Chemical method mainly uses lipids , peptides , polymers and other chemical substances , such substances are with a positive charge , through the role of charge-coupled it can carry DNA with negative charge into cells .

  13. 方法以乳液共聚法制备多聚体UCA;

    Methods The self - designed polymeric UCA were prepared by means of emulsion copolymerization .

  14. 结果,处理后血浆中IgG以及主要蛋白质的分子量都无明显变化,但少量蛋白分子有多聚体形成;

    The results showed that the molecular weight of IgG and main proteins in plasma had no obvious change , but a few protein mole - cules formed polymers .

  15. VWF在血浆中是以多聚体的形式存在的,其分子量介于500~20000kDa之间。

    VWF is present in the form of multimeric glycoprotein in plasma and the molecular weight varies between 500 and 20,000 kDa .

  16. C2327S突变影响多聚体形成。结论:本研究建立的方法和推荐的组合实验适合于绝大多数vWD患者的诊断和分型需要。

    Conclusions Combination of the tests is qualified for the diagnosis of vWD .

  17. 新型抗体HLA-肽多聚体的制备及其对特异性CTLs的检测和诱导的研究

    Preparation of the Novel Antibody HLA - peptide Polymers and Study of the Detection and Induction of Specific CTLs

  18. 结论布洛芬聚乳酸微球对治疗CVS有效,对多聚体技术在脑血管疾病的应用有一定的指导意义。

    Conclusion : The ibuprofen polylactide microspheres could treat CVS effectively and the technique with polymer should guide the therapy of cerebral vascular disease to some extent .

  19. 鞭毛蛋白由两个鞭毛素基因(flaA和flaB)编码的FlaA、FlaB蛋白多聚体组成。

    The flagellin consist of FlaA and FlaB protein by flagella gene flaA and flaB coding .

  20. 方法:以阳离子多聚体(PEI)为阳离子示踪剂,采用体外标记法检测PHN不同时相肾小球基膜阴电荷分布情况。

    Methods : Distribution of negative charges in different phases of PHN on glomerular basement membrane were measured with label method with polyethyleneimine ( PEI ) in vitro as a cation tracer .

  21. 现在我们得到的木质素多聚体是有一个蛋白插入其中的。Carlson解释说,他和Tien以及Liang一起,对这一方法起草了一份临时专利。

    " Now we have a lignin polymer with a protein stuck in between ," explained Carlson , who , along with Tien and Liang , has filed a provisional patent on the approach .

  22. 对可疑vWD患者测定血小板、出血时间、活化部分凝血活酶时间(APTT)、血小板聚集试验(RIPA)、FVⅢ:C、vWF:RCo、vWF:Ag、vWF:CB,并进行多聚体分析。

    Platelets , bleeding time , activation partial thromboplastin time ( APTT ) , RIPA , FV ⅲ: C , vWF : RCo , vWF : Ag and vWF : CB were determined in plasma of ten patients .

  23. 多聚体缓释化疗治疗脑胶质瘤

    Implantable slow-release chemotherapeutic polymers for the treatment of malignant brain tumors

  24. 愈创木基型多聚体木素模型物合成工艺条件的优化

    Optimization of Synthesis Process Conditions of Polymeric Guaiacyl-type Lignin Model Compound

  25. 三氧化物多聚体盖髓剂的研究进展

    Progression of research on mineral trioxide aggregate as a pulp capping material

  26. 另外,在聚集发生前,亚基已自组装形成各种形状的多聚体,然后多聚体进一步聚集形成各种圆环或圆面状。

    Before aggregation , the monomers self - assembled into different shapes .

  27. 叶绿素a二水多聚体电极的光电效应

    The photovoltaic effects of the chlorophyll-a dihydrate aggregate electrode

  28. ⑵催产素受体多聚体单体间以共价键(二硫键)结合。

    ⑵ the monomer of OTR multimer connected covalently ( disulfide bond ) .

  29. 气相色谱法对乙醛多聚体的质量全分析

    A complete Analysis of Acetaldehyde Polymer by Gas Chromatography

  30. 复性过程中形成中间体和多聚体是蛋白质复性的最大问题所在,中间体阻碍作用大,蛋白质正确折叠困难,复性就困难。

    The formation of intermediates and polymers is the biggest problem for protein refolding .